CellSource Co (TSE:4880) Debt-to-Revenue : 0.00 (As of Jan. 2024)

CellSource Co Debt-to-Revenue Chart

CellSource Co Quarterly Data
	Oct18	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Debt-to-Revenue	Get a 7-Day Free Trial															-	-	-	0.02	-

Competitive Comparison of CellSource Co's Debt-to-Revenue

For the Biotechnology subindustry, CellSource Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CellSource Co's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellSource Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where CellSource Co's Debt-to-Revenue falls into.

CellSource Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

CellSource Co's Debt-to-Revenue for the fiscal year that ended in Oct. 2023 is calculated as

CellSource Co's annualized Debt-to-Revenue for the quarter that ended in Jan. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jan. 2024) Revenue data.

CellSource Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of CellSource Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

CellSource Co (TSE:4880) Business Description